Filovirus drug discovery using novel combinations of approved drugs

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: DAMD17-05-C-0129
Agency Tracking Number: C051-119-0150
Amount: $749,926.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: CBD05-119
Solicitation Number: 2005.1
Solicitation Year: 2005
Award Year: 2006
Award Start Date (Proposal Award Date): 2006-03-16
Award End Date (Contract End Date): 2008-06-16
Small Business Information
893 N. Warson Road, St. Louis, MO, 63141
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Paul Olivo
 President & CSO
 (314) 812-8144
Business Contact
 L. Milton
Title: Vice President, HR & Adm
Phone: (314) 812-8160
Research Institution
The goal of this proposal is to find novel combinations of approved drugs for the treatment and/or prevention of infection with filoviruses. Ebola and Marburg viruses, the only filoviruses, cause an acute hemorrhagic fever syndrome which has a high mortality rate and poses a significant bio-terrorism threat. There are currently no therapeutic agents available to treat filovirus infections and the development of such drugs is important for bio-defense. Apath has developed a novel, cell-based, infection-independent screening method that is based on replication of an Ebola virus minigenome. This proposal focuses on a strategy of combining existing drugs to discover combinations that have novel anti-filovirus activity. The Apath screening method is very amenable to identifying drug combinations that inhibit EBOV replication. This method streamlines the process of defining chemical relationships to enable the discovery of combinations of drugs that exhibit novel synergistic activity. The use of a library of approved drugs together with inhibitors discovered by Apath should facilitate the development of a therapeutic drug combination. We will characterize the most potent combinations for antiviral activity and perform preliminary medicinal chemistry and pharmacokinetic studies.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government